Ultragenyx Pharmaceutical Inc Receives PRIME Designation for Groundbreaking Angelman Syndrome Treatment
Ultragenyx Pharmaceutical Inc. has recently been granted PRIME (Priority Medicines) designation by the European Medicines Agency (EMA) for its groundbreaking ...